DOCSLIB.ORG

For Molecular Biosystems

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
For Molecular Biosystems Electronic Supplementary Material (ESI) for Molecular BioSystems. This journal is © The Royal Society of Chemistry 2015 Supplementary Table 1. 109 D/E-rich repeats containing proteins in yeast UniProt D/E-rich repeats Protein function Residue pI Start number Length Histone, nucleosome and kinetochore proteins O74515 VQPDADEEEEEEEADEMEEEFDEEGEGDEEEEEEDDGDGDGEGDGDGE ASF1_SCHPO Histone chaperone cia1 262 3.57 170 48 Q759F6 EAEDEYPPEQPGVDDEEVDDEDEDEDEDEEGADEEGADEEGASDG ASF1_ASHGO Histone chaperone ASF1 276 3.62 155 45 RKVQTEDEEDDEAEEIDLEAEEEEDEDEEDEDGDEAEEVDEEEEDDDGEPVGA 206 55 SE Q59MV1 DNEEGADEYPPEQPEDEEEEEEEEEEGEEEEEDEDEEDDDDDEDLNGDAVVDL ASF1_CANAL Histone chaperone ASF1 247 3.62 154 58 EKEEI P32447 EGDLYPPEQPGVDDEEEEDDEEEDDDEDDEDDEDDDQEDGEGEAEEAAEEEEE ASF1_YEAST Histone chaperone ASF1 279 3.73 158 62 EEEKTEDNE Q59RN6 TENNEEGDDDDEDEDDDYEQGKLEDEEEEEDELLEIDES CHZ1_CANAL Histone H2A.Z-specific chaperone CHZ1 167 4.02 73 39 Q5AQ47 SSSSSSDNDQDNDEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEESEINGN HST1_CANAL NAD-dependent protein deacetylase HST1 657 4.23 68 57 QISL Q8WZM0 IEDEDFQENGIDDEDEEEEEEEAKDEGDEDDEEKGEDDEEDDEEKEGEDGEGE GCN5_YARLI Histone acetyltransferase GCN5 464 4.67 30 71 EEDEEEDEEKKREEEEKY P34218 KEDEDEDEDFTLDDDIEDEQISEENDEEEDTYEEDSDDDEDG SAS3_YEAST Histone acetyltransferase SAS3 831 6.13 755 42 P53165 DDDNSNDNNNDDDDDDDNDDNEDDDDADDDDD SGF73_YEAST SAGA-associated factor 73 657 9.13 131 32 P32657 MTTIEDDEDEFEDEEGEEDSGEDEDEEDFEEDDDYYGS CHD1_YEAST Chromo domain-containing protein 1 1468 6.15 53 38 P40340 AHDPEEDDESFHEEDVDDDEEEEEADEFEDEYLDEDS TBP7_YEAST Tat-binding homolog 7 1379 4.93 116 37 P25293 AALEFEFEEDEEEADEDEDEEEDDDHGLEDDDGESAEEQDDF NAP1_YEAST Nucleosome assembly protein 417 4.09 363 42 Q9HGN2 TEAMTEEASDEDESVDLEEDEEEEDEEDEEGDEEKQEPPS YO48_SCHPO Putative nucleosome assembly protein 244 4.16 198 40 C36B7.08c Q12386 SVDPRDVADEEDEDEEGEDEDEDEDDNDVDNEDENDNDNANE ARP8_YEAST Actin-like protein ARP8 881 4.54 70 42 P54784 DVSEDMDSGEISADELEEEEDEEEDEDEEEKEA ORC1_YEAST Origin recognition complex subunit 1 914 5.42 267 33 Q6CA87 VEEVEEEEPEEEEGPEEEEAPEEEVEGDDEEEVQ SWR1_YARLI Helicase SWR1 1772 4.68 123 34 LKEEMTAVEEEEEEELVEEEEEEEEEEEQEEDEEQEQQEEEEEEQEEEVTSR 275 52 LDNIKVERAEEEDEEDEENGDDEDEDEEEDDAEIEEETETTTP 718 43 AIEEDEEEDDAFVIKEEEEEVEVEDDEEEEKAD 816 33 P31380 QSEHEDDDYEEEDEDYNDEEEDVEYDDGDDDDDDDDEFVAT FUN30_YEAST ATP-dependent helicase FUN30 1131 5.12 497 41 P53115 SDIINEKDADEDEEDDEDELEDGEEDMEEDEASTG INO80_YEAST Putative DNA helicase INO80 1489 5.47 132 35 DNENENDNDSDNDDEEENGEEDEEEEEIEDLDEEDFAAFEEQDDNDDEDF 240 50 Q74Z27 RELSGAKLEDEGEGEDDDEEEDEDDEDDEDEDEDEDEEEEEEEELEELEDIQL INO80_ASHGO Putative DNA helicase INO80 1414 6.36 178 62 LDDDNDKDF Q6C931 LDLESDDEDQEEEESEFEVSDDEPEDEDEDSEEFA SPT16_YARLI FACT complex subunit SPT16 1003 5.07 931 35 Transcription factors P38915 ENDSKQDLEGNDDGGEDEEDDDDDDEDDDDDEDEREDDDEQEDDDGEDDAARM SPT8_YEAST Transcription factor SPT8 602 4.13 28 56 DKT Q6C9G2 ALYDDEDEDGDGADGFIDEDDEDDEEDDEEGEGNGFIDDEVEVDEEDQDEDGD BFR2_YARLI Protein BFR2 495 4.18 78 75 EDMEDEQDEDESDEELSENEND Q5ACL9 EELDAESAEEEEDEESEDVADDDEDDQESD BFR2_CANAL Protein BFR2 482 4.24 366 43 Q06631 ENEDEEEEEEEEEEKEEDALSFRTDSEDEEVE BFR2_YEAST Protein BFR2 590 4.34 507 51 P36100 KKQAKLNKEEEEEEEEEEDEEEEEEEEMEDVMDDNDETARENA T2EA_YEAST Transcription initiation factor IIE subunit alpha 990 4.81 91 45 Q05021 RSDAETANNVEEEEEEEEEEEEEDEVDEDEEDDEENDEDEDNVHEREHIQE TAF7_YEAST Transcription initiation factor TFIID subunit 7 956 4.88 58 45 O13936 NDKKEDEDNVEENEEEADANEEEEEDEEDDEEDEEDEDESGGGRR SPT5_SCHPO Transcription elongation factor spt5 1063 4.95 134 44 Q5ALX3 EENNEKEQDQEAGQDEEEQDEDEEEEEDDEEEDEEDEVSSRRKRR SPT5_CANAL Transcription elongation factor SPT5 980 5.02 29 47 P27692 KNSDGDTKDEGDNKDEDDDEDDDDDDDDEDDDDEAPTKRRRQER SPT5_YEAST Transcription elongation factor SPT5 720 5.19 606 45 Q6CC84 IKSEEVDKTQDNVEDEDDEEEEEEEEEEEEEDDDEEDVRQRKKPRRE SPT5_YARLI Transcription elongation factor SPT5 683 6.31 526 36 Q59P39 PNTAENDVPGDDEEEEDDDDDDDDDEEEGEQDDEEEEDGSSTSMS EFH1_CANAL Transcriptional regulator EFH1 719 8.00 541 30 P32432 SQNMVEDQDIDDIDDDDDVDDDDDDDDDDDTENGSS SFP1_YEAST Transcription factor SFP1 512 4.46 106 30 Q03213 EDDDDDGDDEGDGRDNEEDSTAEEDEVDDE HOT1_YEAST High-osmolarity-induced transcription protein 1 534 4.53 96 32 P32351 DVDSEEEGEGNDEDDDDGDGDDMDEEESDEEQ IMPX_YEAST Sugar utilization regulatory protein IMP2 346 4.81 95 32 P08638 DEEEEEDEDEEGEEEEEEEELSSKVPENMD LEUR_YEAST Regulatory protein LEU3 886 5.75 678 30 P38114 SNNNDNDNNINDDDDDDDDDDDDDDDDDDDDDNDDDYSNNGADDDEEDDDYDR TBS1_YEAST Uncharacterized transcriptional regulatory 1094 5.12 981 53 protein TBS1 RNA polymerase subunits P38439 NEYEEDDFLVDDDEEEEAAFDDEEDDNEEEEEEEDADEENASR LEO1_YEAST RNA polymerase-associated protein LEO1 464 4.17 382 43 P36070 QNELDELDDDVDDDDLEEVDLEDDDDLDDDSGDDDDENC RRN3_YEAST RNA polymerase I-specific transcription 627 4.44 245 39 initiation factor RRN3 Q5ALX5 SDNEGGEDIEDDDNDYEDEGDDDEEEEGEEEEEEESDEDEISDIGKS SSN2_CANAL Mediator of RNA polymerase II transcription 1665 4.53 679 47 subunit 13 Q05543 YEVGDGDDDDDDGDNDDDDDDDDDDKNYDDRSND RT103_YEAST Regulator of Ty1 transposition protein 103 409 4.63 263 34 P33441 DEKEESDHEYDDQEDEENEEEDDMEVDVED MFT1_YEAST THO complex subunit MFT1 392 4.27 292 30 Ribosomal proteins Q06672 RVVHIEGDDDEDDEDVEDYDDEDEDEEMDEVVPDLVS TSR2_YEAST Pre-rRNA-processing protein TSR2 205 3.97 146 37 P39520 DYQAVTDGEESENEEEESEEEEEDDDEDDDDDDDDGSDSDSDSETSSDDEN IFH1_YEAST Protein IFH1 1085 4.37 114 51 Q12136 LLEDEDEEEVLAMDEDDESIDEREDEEEEEEEELDG SAS10_YEAST Something about silencing protein 10 610 4.45 54 36 Q59VP7 SDDEDEEEEQEQEEQPQEEENNSDDDDDDDDDDDDN ERB1_CANAL Ribosome biogenesis protein ERB1 849 4.46 51 36 SSQKEEDNKESDNEDEDEEEDNDDDDDDDEPETSS 571 35 RNA processing Q751K8 RARGADDGDVDMLDDDDEEEDDDEDEDDEDSDSDVEIIIG FIP1_ASHGO Pre-mRNA polyadenylation factor FIP1 323 4.06 60 40 P38996 TEEEEEEEHQQKGGNDDDDDDNEEEEEEEEDDDDDDDDDDDDEEEEEEEEEEG NAB3_YEAST Nuclear polyadenylated RNA-binding protein 3 802 4.25 86 63 NDNSSVGSDS Q6C233 DGNGQLVDDYDDDEDDDDEDDEIDEEVDDDLIADENAVDV SQS1_YARLI Protein SQS1 812 4.31 207 40 Q5AFT3 LCFLPFEVIEDDEDEEEEEEEDEEDEDEGEENIDDTKEKKDKK CFT1_CANAL Protein CFT1 1420 4.94 149 43 KIEEKEDNKDDDDNDDDDEDDLYKEEEEEETQ 454 32 P38798 PGKHQAKQDESEDEDDEDDDEDDDDDDDDDDDDGEEGDEDDDEDDDDEDDDDE NMD2_YEAST Nonsense-mediated mRNA decay protein 2 1089 4.85 876 73 EEEDSDSDLEYGGDLDADRD Q9P6R9 GEEDDDENEEDEEDSEETSESEEDESVNDEK CWC22_SCHPO Pre-mRNA-splicing factor cwf22 887 8.66 368 31 Q6C8C5 KEILGDSDDEEEDDSEAEEEADDEEEEEGDEEEEAQAST CWC22_YARLI Pre-mRNA-splicing factor CWC22 954 8.94 464 39 P11745 SKFDDLEVDDFEEVDSEDEEGEDEEDEDEDEKLEEIETERLEKE RNA1_YEAST Ran GTPase-activating protein 1 407 4.39 345 44 P53107 GYEAIEEDEEEDEEEDEEEGKDGEERKEEEEEENKLEDKD YRB30_YEAST Ran-specific GTPase-activating protein 30 440 4.55 337 40 Q6CFG6 APKKAKVEEEESDDDEEDEEDDDDDDDSDDDDSDDSGEPQMEIK EFG1P_YARLI rRNA-processing protein EFG1 305 4.44 218 44 O74363 FADLSVLEEDDDDEDEDEELEGEKEEEEEEKEKPEISN YND2_SCHPO G-patch and R3H domain-containing protein 695 4.65 257 38 C30B4.02c Q6CEW9 KGDDEIDEDEDEEEESENKKDDDNEEAEEDEEDPVIED MRD1_YARLI Multiple RNA-binding domain-containing 828 4.98 192 38 protein 1 Q6CAC9 EQELEEDDIEGAGEEEEEVDEEQEEEEDADDAEEDAEDDSETDKYD UTP25_YARLI U3 small nucleolar RNA-associated protein 25 641 5.14 46 46 C4R2K0 KLEEEQEREEEELQEEDEDEDEEDEEINLEDFESDDESHDD UTP25_PICPG U3 small nucleolar RNA-associated protein 25 697 5.56 102 41 Q6CFT1 DFFELAGKTDDGDDEEEDEEDEEEEEEEKE ESF2_YARLI Pre-rRNA-processing protein ESF2 324 5.33 65 30 Q6C2F4 DFENSEEEGEDDEDEAEDDDDEDVEIHEVDEDEDESGDKS NOP14_YARLI Probable nucleolar complex protein 14 832 5.42 360 40 Q6C2Q7 VDPVRDQQEDKMEVEDEEEDEEEDEEDEEEDEEDEEDEEEKEEDDDDDDDEEE NOP12_YARLI Nucleolar protein 12 509 5.47 30 63 IEEPVIKKSK Q59X38 EKEDGEAVEDTDEEEEEVEIEDGDEDQEDEEEEEDEDLKAQKE PESC_CANAL Pescadillo homolog 587 6.13 458 43 Q6C1W9 EGAEGNDEEDDEDDDDEEEEEEESVSAEPEVVE TRM10_YARLI tRNA (guanine(9)-N1)-methyltransferase 371 5.00 318 33 RNA helicase Q59MW2 DEEEEEEETDESEHESSQDEDINEEEPEEEDED DBP6_CANAL ATP-dependent RNA helicase DBP6 606 4.81 39 33 P32892 MNNGDENQSEEEEEEEEKEEEEEEEEEQEEMTLEKGGKDDE DRS1_YEAST ATP-dependent RNA helicase DRS1 752 5.47 161 41 Q59ZH9 DVEDNETPEVEDEKPTEQEEEEEEEEEEEEEEEEEEEEEEFAGFEDDENNQED MAK5_CANAL ATP-dependent RNA helicase MAK5 782 5.75 97 55 AN Translation Q12532 KVKTSGNEDNGDDDEEEEEEEEEEEEEEEEEEEEEEEEKEEEEKEEEQQQDED TAE2_YEAST Translation-associated element 2 1038 5.47 706 59 DSNEVN Protein-protein interaction Q59S52 KDSGYNSQNLDDEDEDDEDDDEDDEDEEEEDEDDYDDHDLGTINEGI MDM12_CANAL Mitochondrial distribution and morphology 428 3.90 97 47 protein 12 Q12500 EEVGNSEDNEDDDTDEDSEDDDDDGGDDDDSEDDDDDDDGEGDENGDDGEGDE AVL9_YEAST Late secretory pathway protein AVL9 764 4.20 596 57 NGDD P38835 TTKDAEDHGEDDGDGDDGEDDDDDDDDDDDDDDDEDDDDDDDDDDDDDDDDDD YHT1_YEAST PH domain-containing protein YHR131C 850 5.02 793 57 GQIT P40021 NDESSENGDGDNDHDDDYDDDDDDDDDDDESE ZRG8_YEAST Zinc-regulated protein 8 1076 4.60 420 32 Q08979 DEDEFEYEDDEEDEDDGEEEQDAGPLEGDEDEESESDDD KEL3_YEAST Kelch repeat-containing protein 3 651 4.88 518 39 Q99299 IFDGVTVRADEEEEEDEDDEDDEEEEEENDDEEDEEDEEDDEDDEEEEEKRKE AIM44_YEAST Altered inheritance of mitochondria protein 44 758 6.31 642 60 GEGRNLA P48362 EEMPSKNAEEEEEEESEEEEDDDEEDEIVE HGH1_YEAST FAM203 family protein HGH1 394 4.48 363 30 Ubiquitin related proteins Q10435 GSESYERDEDVDEEEEEDDDENNDEGDDEDENENDELRSEN YDE1_SCHPO Probable ubiquitin fusion degradation protein 1647 4.82 240 41 C12B10.01c O74201 VRETVENSWNDDDDEEEEEEDEDEAEDEDDDDDDNIDE UBC2_CANAL Ubiquitin-conjugating enzyme E2 2 179 3.92 141 38 P06104 VKETVEKSWEDDMDDMDDDDDDDDDDDDDEA UBC2_YEAST Ubiquitin-conjugating enzyme E2 2 172 4.02 141 31 Q12161
Load more

Recommended publications
  • Ligand-Induced Conformational Rearrangements Promote Interaction Between The
    Ligand-Induced Conformational Rearrangements Promote Interaction between the Escherichia coli Enterobactin Biosynthetic Proteins EntE and EntB† †This work was supported by Discovery Grant 341983-07 from the Natural Sciences and Engi- neering Research Council of Canada to PDP Sofia Khalil and Peter D. Pawelek* Department of Chemistry and Biochemistry, Concordia University, 7141 Sherbrooke St., W., Montreal, Quebec, Canada, H4B 1R6 *Correspondence should be addressed to: Peter D. Pawelek, Tel: 514-848-2424 ext. 3118; Fax: 514-848-2868; E-mail: [email protected] Running title: Efficient EntE-EntB interaction requires 2,3-dihydroxybenzoic acid Abbreviations The following abbreviations are used in this manuscript: 2,3-DHB: 2,3-dihydroxybenzoic acid; 2,5-DHB: 2,5-dihydroxybenzoic acid; 3,5-DHB: 3,5-dihydroxybenzoic acid; AMP: adenosine monophosphate; ArCP: aryl carrier protein; ATP: adenosine triphosphate; CD: circular dichro- ism; DTT: dithiothreitol; FRET: fluorescence resonance energy transfer; H6-EntB: purified, re- combinant hexahistidine-tagged E. coli EntB; H6-EntE: purified, recombinant hexahistidine- tagged E. coli EntE; ICL: isochorismate lyase; ITC: isothermal titration calorimetry; NRPS: non- ribosomal peptide synthesis; PDB: Protein Data Bank; RMSD: root mean square deviation; SDS- PAGE: sodium dodecyl sulfate polyacrylamide gel electrophoresis; TCEP: tris(2- carboxyethyl)phosphine. 2 Abstract Siderophores are small-molecule iron chelators that many bacteria synthesize and secrete in or- der to survive in iron-depleted environments. Biosynthesis of enterobactin, the E. coli catecho- late siderophore, requires adenylation of 2,3-DHB by the cytoplasmic enzyme EntE. The DHB- AMP product is then transferred to the active site of holo-EntB subsequent to formation of an EntE-EntB complex.
    [Show full text]
  • Curriculum Vitae
    Characterization of Heme Transport in Pseudomonas aeruginosa and the Preferential Pathway for Heme Uptake Item Type dissertation Authors Smith, Aaron Dennison Publication Date 2015 Abstract Bacterial pathogens require iron for their survival and virulence and have evolved multiple mechanisms to acquire this scarce micro-nutrient. The Gram-negative opportunistic pathogen Pseudomonas aeruginosa acquires heme as an iron source through the ... Keywords ABC transporter; iron acquisition; outer membrane receptor; transporter; ATP-Binding Cassette Transporters; Heme; Pseudomonas aeruginosa Download date 24/09/2021 16:37:31 Link to Item http://hdl.handle.net/10713/4622 Curriculum Vitae Aaron Dennison Smith Education: University of Maryland, Baltimore (2008-present) Department of Pharmaceutical Sciences School of Pharmacy GPA: 3.92 Degree: Ph.D. Expected Date of Degree: May 2015 Dissertation: Characterization of Heme Transport in Pseudomonas aeruginosa and the Preferential Pathway for Heme Uptake University of Maryland Baltimore County (2002-2007) Department of Biochemistry and Molecular Biology GPA: 3.1 Degree: B.S. Date of Degree: July 2007 Employment: Graduate Research Assistant (2008-present) Department of Pharmaceutical Sciences School of Pharmacy, University of Maryland, Baltimore Technical Director (2006-2008) Chemspec, Inc. Baltimore, MD Teaching Experience: Teaching Assistant (2008-2009) School of Pharmacy, University of Maryland, Baltimore PharmD courses: Medicinal Chemistry, Microbiology, Pharmacokinetics Resource Teacher (2006) Vertically Integrated Partnerships K-16 Internship University of Maryland Baltimore County Leadership Opportunities: Graduate Recruitment Strategies Taskforce Committee (2012-2013) President: Pharmacy Graduate Student Association (2009-2010) Team Captain: PSC Race for the Cure (2008-2010) Presentations: Characterization of the outer membrane heme receptors and the preferential pathway for heme uptake in Pseudomonas aeruginosa.
    [Show full text]
  • Structure of the Entb Multidomain Nonribosomal Peptide Synthetase and Functional Analysis of Its Interaction with the Ente Adenylation Domain
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Chemistry & Biology 13, 409–419, April 2006 ª2006 Elsevier Ltd All rights reserved DOI 10.1016/j.chembiol.2006.02.005 Structure of the EntB Multidomain Nonribosomal Peptide Synthetase and Functional Analysis of Its Interaction with the EntE Adenylation Domain Eric J. Drake,1,2 David A. Nicolai,1 a downstream domain. Additional catalytic domains and Andrew M. Gulick1,2,* that exist in NRPSs include N-methylation and epimeri- 1 Hautpman-Woodward Medical Research Institute zation domains [1, 5]. The NRPS carrier protein domains 700 Ellicott Street contain a conserved serine that is posttranslationally Buffalo, New York 14203 modified by holo-ACP synthases with a PPant cofactor 2 Department of Structural Biology [6] and are similar to acyl carrier proteins involved in The State University of New York at Buffalo other cellular processes, including fatty acid biosynthe- Buffalo, New York 14260 sis and metabolism and polyketide biosynthesis. E. coli contains a single NRPS system that is used in the synthesis of the siderophore enterobactin (Fig- Summary ure 1A). The enterobactin molecule contains three cop- ies of a dipeptide of 2,3-dihydroxybenzoic acid (DHB) Nonribosomal peptide synthetases are modular pro- and serine [7]. The serine molecules form a trilactone teins that operate in an assembly line fashion to ring between the carboxylate of one residue and the bind, modify, and link amino acids. In the E. coli entero- side chain hydroxyl of the next. Produced and secreted bactin NRPS system, the EntE adenylation domain during iron-limiting conditions, the enterobactin mole- catalyzes the transfer of a molecule of 2,3-dihydroxy- cule chelates an Fe3+ ion and is then taken up into the benzoic acid to the pantetheine cofactor of EntB.
    [Show full text]
  • Iron Transport Machinery: a Potential Therapeutic Target in Escherichia Coli Clorissa L
    University of South Carolina Scholar Commons Theses and Dissertations 2018 Iron Transport Machinery: A Potential Therapeutic Target In Escherichia Coli Clorissa L. Washington – Hughes University of South Carolina Follow this and additional works at: https://scholarcommons.sc.edu/etd Part of the Chemistry Commons Recommended Citation Washington – Hughes, C. L.(2018). Iron Transport Machinery: A Potential Therapeutic Target In Escherichia Coli. (Doctoral dissertation). Retrieved from https://scholarcommons.sc.edu/etd/4885 This Open Access Dissertation is brought to you by Scholar Commons. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. IRON TRANSPORT MACHINERY: A POTENTIAL THERAPEUTIC TARGET IN ESCHERICHIA COLI by Clorissa L. Washington – Hughes Bachelor of Science Benedict College, 2009 Submitted in Partial Fulfillment of the Requirements For the Degree of Doctor of Philosophy in Chemistry College of Arts and Sciences University of South Carolina 2018 Accepted by: F. Wayne Outten, Major Professor John H. Dawson, Committee Member Sheryl L. Wiskur, Committee Member Beth Krizek, Committee Member Cheryl L. Addy, Vice Provost and Dean of the Graduate School © Copyright Clorissa L. Washington-Hughes, 2018 All Rights Reserved ii DEDICATION Dedicated to my father, Billy Wayne Washington, Sr. and my great – grandfather, Bishop Wallace Snow iii ACKNOWLEDGEMENTS First, I would like to thank my Lord and Savior Jesus Christ for allowing me to start and complete my PhD journey. I would like to thank my research advisor, Dr. F. Wayne Outten for accepting me into his laboratory. When I first started in the lab, I had no idea what I was in for.
    [Show full text]
  • Copyright by Nicola Mary Lisa Davies 2006
    Copyright by Nicola Mary Lisa Davies 2006 The Dissertation Committee for Nicola Mary Lisa Davies Certifies that this is the approved version of the following dissertation: Iron Acquisition by Shigella dysenteriae and Shigella flexneri Committee: Shelley M. Payne, Supervisor Charles F. Earhart Richard J. Meyer Ian J. Molineux Martin Poenie Iron Acquisition by Shigella dysenteriae and Shigella flexneri by Nicola Mary Lisa Davies, B.Sc.H. Dissertation Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy The University of Texas at Austin August 2006 Dedication To Dad and Mark Acknowledgements I would like to thank Shelley Payne for her patience, support and guidance over the last five years. I would also like to acknowledge the support and assistance of all of the members of the Payne lab. I am especially grateful to Erin Murphy and Alexandra Mey for many scientific discussions and excellent suggestions, and to Keren Hilgendorf for technical assistance. v Iron Acquisition by Shigella dysenteriae and Shigella flexneri Publication No._____________ Nicola Mary Lisa Davies, PhD The University of Texas at Austin, 2006 Supervisor: Shelley M. Payne Shigella dysenteriae and Shigella flexneri are Gram-negative facultative intracellular pathogens that cause bacillary dysentery. Iron is an essential micronutrient for these pathogens and they have evolved several systems to obtain iron. The Feo and Sit systems are involved in acquisition of ferrous iron and the TonB-dependant systems transport ferric iron and heme. In S. flexneri, a strain with a defect in the Sit system exhibited decreased fitness in the intracellular environment compared to the wild type.
    [Show full text]
  • 1 Universidade De São Paulo Faculdade De Medicina De
    1 UNIVERSIDADE DE SÃO PAULO FACULDADE DE MEDICINA DE RIBEIRÃO PRETO PROGRAMA DE PÓS-GRADUAÇÃO EM BIOLOGIA CELULAR E MOLECULAR MARISTELA PREVIATO MELLO Caracterização funcional de fatores de transcrição da família MarR de Chromobacterium violaceum Ribeirão Preto 2018 2 UNIVERSIDADE DE SÃO PAULO FACULDADE DE MEDICINA DE RIBEIRÃO PRETO PROGRAMA DE PÓS-GRADUAÇÃO EM BIOLOGIA CELULAR E MOLECULAR MARISTELA PREVIATO MELLO Caracterização funcional de fatores de transcrição da família MarR de Chromobacterium violaceum Orientador: Prof. Dr. José Freire da Silva Neto Ribeirão Preto 2018 1 MARISTELA PREVIATO MELLO Caracterização funcional de fatores de transcrição da família MarR de Chromobacterium violaceum Versão Original Tese apresentada à Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo para obtenção do título de Doutor em Ciências. Área de concentração: Biologia Celular e Molecular Orientador: Prof. Dr. José Freire da Silva Neto Ribeirão Preto 2018 2 Autorizo a reprodução e divulgação total ou parcial deste trabalho, por qualquer meio convencional ou eletrônico, para fins de estudo e pesquisa, desde que citada a fonte. Previato-Mello, Maristela Caracterização funcional de fatores de transcrição da família MarR de Chromobacterium violaceum. Ribeirão Preto, 2018. 151 p. : il. ; 30 cm Tese de Doutorado, apresentada à Faculdade de Medicina de Ribeirão Preto/USP. Área de concentração: Biologia Celular e Molecular. Orientador: da Silva Neto, José Freire. 1. Biologia Celular. 2. Biologia Molecular. 3. Microbiologia. 4. Regulação gênica. 5. Reguladores transcricionais da família MarR. 3 Candidata: PREVIATO-MELLO, Maristela. Título da Tese: Caracterização funcional de fatores de transcrição da família MarR de Chromobacterium violaceum. Tese apresentada à Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo para obtenção do título de Doutor em Ciências.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0244489 A1 MASIGNAN Et Al
    US 20160244489A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2016/0244489 A1 MASIGNAN et al. (43) Pub. Date: Aug. 25, 2016 (54) PROTEINS AND NUCLEICACIDS FROM application No. 1 1/884,812, filed on Mar. 26, 2008, MENINGITIS/SEPSIS-ASSOCATED now Pat. No. 8,758,764, filed as application No. PCT/ ESCHERICHA COL US2006/005913 on Feb. 17, 2006. (71) Applicants: GlaxoSmithKline Biologicals SA, (60) Provisional application No. 60/712,720, filed on Aug. Rixensart (BE); J. Craig Venter 29, 2005, provisional application No. 60/654,632, Institute, Inc., Rockville, MD (US) filed on Feb. 18, 2005. (72) Inventors: Vega MASIGNANI, Siena (IT): Danilo Gomes MORIEL, Monteriggioni (IT): Publication Classification Francesco BERLANDA SCORZA, Trento (IT): Nathalie NORAIS, Siena (51) Int. Cl. (IT): Maria Rita FONTANA, Siena C07K I4/245 (2006.01) (IT); Mariagrazia PIZZA, Siena (IT): A6139/08 (2006.01) Laura SERINO, Monticiano (IT): C07K 6/2 (2006.01) Herve TETTELIN, Gaithersburg, MD (52) U.S. Cl. (US) CPC ........... C07K 14/245 (2013.01); C07K 16/1232 (73) Assignees: GlaxoSmithKline Biologicals SA, (2013.01); A61 K39/0258 (2013.01); A61 K Rixensart (BE); J. Craig Venter 2039/523 (2013.01) Institute, Inc., Rockville, MD (US) (21) Appl. No.: 15/150,204 (57) ABSTRACT (22) Filed: May 9, 2016 Disclosed herein are various open reading frames from a Related U.S. Application Data strain of E. coli responsible for neonatal meningitis (MNEC), (62) Division of application No. 14/293,967, filed on Jun. 2, and a Subset of these that is of particular interest for preparing 2014, now Pat.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,758,764 B2 Masignani Et Al
    US008758764B2 (12) United States Patent (10) Patent No.: US 8,758,764 B2 Masignani et al. (45) Date of Patent: Jun. 24, 2014 (54) PROTEINS AND NUCLEICACIDS FROM WO WO-O2/O771.83 10, 2002 MENINGITIS/SEPSIS-ASSOCATED WO WO-2004/005535 A2 1/2004 ESCHERICHLA COLI WO WO-2005, O76O10 8, 2005 (75) Inventors: Vega Masignani, Siena (IT); Danilo OTHER PUBLICATIONS Gomes Moriel, Monteriggioni (IT): Houghten et al. (New Approaches to Immunization, Vaccines36, Francesco Berlanda Scorza, Trento Cold Spring Harbor Laboratory, p. 21-25, 1986.* (IT): Nathalie Norais, Siena (IT): Maria McGuinness et al. (Lancet 337: 514-517, Mar. 1991.* Rita Fontana, Siena (IT); Mariagrazia McGuinness et al. (Mol. Microbiol. 7:505-514, Feb. 1993).* Pizza, Siena (IT): Laura Serino, Accession No. Q46837 2002 (or Q2M9M2 or Q46838 or Q6BF5) or Monticiano (IT): Herve Tettelin, Science 277:1453-1474(1997).* Gaithersburg, MD (US) EMBL accession No. AJ617685 (Created on May 11, 2004), "Escherichia coli pathogenicity island V. strain 536.” (73) Assignees: Novartis Vaccines and Diagnostics Srl, UniProt accession No. Q46837 (Integrated on Apr. 16, 2002). “Puta Siena (IT); J. Craig Venter Institute, tive lipprotein acflD homolog.” Rockville, MD (US) Hughes et al. (Aug. 19, 1994). “Sequence analysis of the Vibrio cholerae acfD gene reveals the presence of an overlapping reading (*) Notice: Subject to any disclaimer, the term of this frame, orf7, which encodes a protein that shares sequence similarity patent is extended or adjusted under 35 to the FIiA and FIiC products of Salmonella,", Gene 146(1): 79-82. European Search Report mailed Dec. 23, 2008, for EP patent appli U.S.C.
    [Show full text]
  • The Phosphopantetheinyl Transferases: Catalysis of a Post-Translational Modification Crucial for Life† Cite This: Nat
    NPR REVIEW View Article Online View Journal | View Issue The phosphopantetheinyl transferases: catalysis of a post-translational modification crucial for life† Cite this: Nat. Prod. Rep.,2014,31,61 Joris Beld,‡a Eva C. Sonnenschein,‡§a Christopher R. Vickery,‡ab Joseph P. Noelb and Michael D. Burkart*a Covering: up to 2013 Although holo-acyl carrier protein synthase, AcpS, a phosphopantetheinyl transferase (PPTase), was characterized in the 1960s, it was not until the publication of the landmark paper by Lambalot et al. in 1996 that PPTases garnered wide-spread attention being classified as a distinct enzyme superfamily. In the past two decades an increasing number of papers have been published on PPTases ranging from Received 11th June 2013 identification, characterization, structure determination, mutagenesis, inhibition, and engineering in DOI: 10.1039/c3np70054b synthetic biology. In this review, we comprehensively discuss all current knowledge on this class of www.rsc.org/npr enzymes that post-translationally install a 40-phosphopantetheine arm on various carrier proteins. 1 Introduction 4.2 The other phosphopantetheinylated proteins and their 2 Types of PPTases PPTases 2.1 Family I: holo-acyl carrier protein synthase (AcpS-type 4.3 Carrier protein recognition by PPTases PPTases) 4.4 Peptide mimics of carrier proteins as substrate of PPTases 2.2 Family II: Sfp-type PPTases 4.5 Regulation by 40-phosphopantetheinylation 2.3 Family III: type I integrated PPTases 5 Structures 3 Importance in primary and secondary metabolism 5.1 Structural
    [Show full text]
  • Variations on a Theme: Synthesis and Modification of Plant Benzoic Acids
    Variations on a theme: synthesis and modification of plant benzoic acids Mary C Wildermuth Plant benzoic acids (BAs) are critical regulators of a plant’s species of 30 different families and function as pollinator interaction with its environment. In addition, innumerable plant- attractants [3]. In addition, MeSA is involved in tri- derived pharmacological agents contain benzoyl moieties. trophic interactions; MeSA is emitted in response to Despite the prevalence and import of plant BAs, their herbivore damage (e.g. that caused by aphids or mites), biosynthetic pathways are not well-defined. Mounting attracting the predator of the herbivore [3,4]. As shown evidence suggests that BAs are synthesized both directly from in Figure 1, BAs are also incorporated into numerous plant shikimate/chorismate and from phenylalanine in plants; secondary metabolites that have established roles in however, few genes in these pathways have been identified. plant–herbivore or plant–pathogen interactions, such as Exciting progress has been made in elucidating genes that BA glucosinolate esters (e.g. in A. thaliana [5]), salicin (the modify BAs via methylation, glucosylation, or activation with major phenolic glycoside in willow [6]), xanthones (e.g. in Coenzyme A. As these modifications alter the stability, Hypericum androsaemum [7]), cocaine (in Erythroxylum coca solubility, and activity of the BAs, they impact the functional [8]), and taxol (in Taxus cuspidate [9]). Many of these BA roles of these molecules. The combination of multiple BA and benzoyl compounds are also important pharmacolo- biosynthetic routes with a variety of chemical modifications gical agents; for example, salicylate is the active ingre- probably facilitates precise temporal and spatial control over dient in aspirin, taxol is a potent anti-cancer drug, and active forms, as well as the channeling of intermediates to cocaine is a local analgesic.
    [Show full text]
  • Evolution-Guided Optimization of Biosynthetic Pathways
    Evolution-guided optimization of biosynthetic pathways Srivatsan Ramana,b,1,2, Jameson K. Rogersa,c,1, Noah D. Taylora,b,1, and George M. Churcha,b aWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115; bDepartment of Genetics, Harvard Medical School, Boston, MA 02115; and cSchool of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02143 Edited by David Baker, University of Washington, Seattle, WA, and approved October 30, 2014 (received for review May 21, 2014) Engineering biosynthetic pathways for chemical production readout (7). The resulting expression of a fluorescent reporter requires extensive optimization of the host cellular metabolic gene or antibiotic resistance gene allows facile identification of machinery. Because it is challenging to specify a priori an optimal mutant cells with increased production of the target chemical. design, metabolic engineers often need to construct and evaluate Sensor reporters have been used to screen for increased mi- a large number of variants of the pathway. We report a general crobial production of several chemicals, including the isoprenoid strategy that combines targeted genome-wide mutagenesis to precursor mevalonate (8), L-lysine (9, 10), 1-butanol (11), and generate pathway variants with evolution to enrich for rare high triacetic acid lactone (12). These studies evaluated a set of variants that altered the expression or coding sequences of one or two producers. We convert the intracellular presence of the target − chemical into a fitness advantage for the cell by using a sensor do- key enzyme genes encoded on a plasmid (8, 10 12). Similarly, a lysine-responsive sensor reporter was used to uncover new main responsive to the chemical to control a reporter gene necessary endogenous enzyme mutants in Corynebacterium glutamicum for survival under selective conditions.
    [Show full text]
  • Molecular Insights Into Beneficial Effects of Tea-Plant Growth and Selenium Enrichment by Herbaspirillum Camelliae
    Applied Microbiology: Theory & Technology http://ojs.wiserpub.com/index.php/AMTT/ Research Article Molecular Insights into Beneficial Effects of Tea-Plant Growth and Selenium Enrichment by Herbaspirillum camelliae Wei Cheng, Xuejing Yu, Xingguo Wang* State Key Laboratory of Biocatalysis and Enzyme Engineering, the Faculty of Life Science, Hubei University, P.R.China E-mail: [email protected] Received: 7 November 2020; Revised: 19 July 2021; Accepted: 19 July 2021 Abstract: Herbaspirillum camelliae WT00C, as a tea-plant endophytic bacterium, not only colonizes specifically in tea plants but also promotes tea-plant growth and selenium enrichment. Different from diazotrophic endophytes H. seropedicae, H. frisingense and H. rubrisubalbicans, H. camelliae WT00C does not display nitrogen-fixing activity. To understand the molecular mechanisms of promoting the growth of tea plant and Se-enrichment, we sequenced and annotated the genome of H. camelliae WT00C. The results showed that the genome was composed of 6,079,821 base pairs with a total of 5,537 genes. The genomic survey also revealed that H. camelliae WT00C was a multifunctional bacterium metabolizing a variety of carbon and nitrogen sources and defending against biotic and abiotic stress. Although this bacterium did not have intact nitrogen-fixing genes, its genome held the genes responsible for indole- 3-acetic acid (IAA) biosynthesis, 1-aminocyclopropane-1-carboxylate (ACC) deamination, siderophore synthesis, ammonia formation, urea metabolism, glutathione and selenocompound metabolisms. Biosynthesis of IAA, siderophore, ammonia, urea and ACC deaminase could explain why two bacterial strains promote tea-plant growth and development. Selenocompound metabolism in this bacterium might also benefit tea-plant growth and Se-enrichment.
    [Show full text]